We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Nanotechnology Approach Locates and Removes Dangerous Endometriosis Lesions

By HospiMedica International staff writers
Posted on 27 Apr 2022
Print article
Image: Nanoparticles show promise for locating, removing endometriosis lesions (Photo courtesy of OSU)
Image: Nanoparticles show promise for locating, removing endometriosis lesions (Photo courtesy of OSU)

Endometriosis is a common gynecological condition in women of childbearing age. The endometrium is the innermost layer of the uterus, and endometriosis occurs when endometrium-like tissue forms lesions outside of the uterine cavity – usually involving the ovaries, the fallopian tubes and the tissue lining the pelvis. On rare occasions, endometrial tissue may spread beyond the pelvic region. There’s no cure for endometriosis, although surgical removal of the lesions can improve fertility. The downside, however, is that the lesions come back about half the time, and more than one-quarter of endometriosis surgery patients need three or more operations because it’s hard to find all of the diseased tissue that needs to be removed. Scientists have now developed a new nanotechnology approach for locating and removing the painful and dangerous lesions associated with endometriosis.

The research led by scientists at the Oregon State University (OSU, Corvallis, OR, USA) involves magnetic nanoparticles - tiny pieces of matter as small as one-billionth of a meter. An animal-model study showed that the iron oxide nanoparticles, injected intravenously, act as a contrast agent – they accumulate in the lesions, making them easier to see by advanced imaging such as MRI. And when exposed to an alternating magnetic field, a non-invasive procedure, the nanoparticles’ temperature soars to more than 120 degrees Fahrenheit, high enough for lesion removal via heat.

Magnetic hyperthermia had not previously been considered as a potential means of ablating endometriosis lesions because other magnetic nanoparticles have relatively low heating efficiency. The nanoparticles could only get hot enough after being directly injected into diseased tissue, which is not a realistic approach for endometriosis. The researchers overcame that problem by developing hexagonal-shaped nanoparticles that have more than six times the heating efficiency of conventional spherical nanoparticles when subjected to an alternating magnetic field.

Modifying the nanoparticles with a peptide - multiple amino acids linked in a chain – that targets a cellular receptor abundant in endometriosis cells enhanced their ability to accumulate in endometriosis lesions, the scientists said. Studies of mice with endometriotic tissue transplanted from macaques demonstrated the nanoparticles’ ability to eradicate the diseased cells following one session of magnetic hyperthermia.

“Endometriosis is a debilitating, systemic disease, and the need for an efficient, non-surgical method of removing the lesions is urgent,” said Oleh Taratula of the Oregon State University College of Pharmacy who led the research. “We invented targeted nanoparticles with extraordinary heating capabilities that enable the use of magnetic hyperthermia for the safe and efficient elimination of endometriosis lesions.”

Related Links:
Oregon State University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.